Evidence map›Paper›PMID 40888415›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2025

Enhanced One-Pot Cas12a-Based Nucleic Acid Detection via Epitope Insertion and Recruitment of Rad51.

Tingting Zhao, Lan Yu, Man Yin, Sisi Huang, Rui Tian, Chaoyue Zhong, Fang Nan, HongFeng Zhang, Xun Tian, Zheng Hu

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tingting ZhaoGenerulor Co., Ltd, Zhuhai, Guangdong, 519031, China.ORCID 0009-0002-3539-4612
Lan YuDepartment of Gynecology and Obstetrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, 510000, China.
Man YinDepartment of Gynecologic Oncology, Women and Children's Hospital Affiliated with Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China.
Sisi HuangHealth Management Center, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430000, China.
Rui TianGenerulor Co., Ltd, Zhuhai, Guangdong, 519031, China.
Chaoyue ZhongGenerulor Co., Ltd, Zhuhai, Guangdong, 519031, China.
Fang NanDepartment of Gynecology, Ezhou Central Hospital, Ezhou, Hubei, 436000, China.
HongFeng ZhangDepartment of Pathology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430014, China.
Xun TianDepartment of Obstetrics and Gynecology, Academician Expert Workstation, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430014, China.
Zheng HuTaikang Center for Life and Medical Sciences, Wuhan University, No.299 Bayi Road, Wuchang, Wuhan, Hubei, 430072, China.ORCID 0000-0001-9306-9442

Funding

China Postdoctoral Science Foundation 2023M734090China Postdoctoral Science Foundation 2023M734091China Postdoctoral Science Foundation 2023M744121Guangdong Special Support Plan Young Top-notch Talent 0820250Key Technology R&D Program of Hubei 2024BCB057National Natural Science Foundation of China 32171465National Natural Science Foundation of China 32371541National Natural Science Foundation of China 82102392National Natural Science Foundation of China 82172584
6 · The paper itself

Abstract

The CRISPR-Cas12a system has emerged as a promising tool for nucleic acid-based diagnostics. However, its multi-step workflow and limited sensitivity hinder its integration into point-of-care testing (POCT). Here, the ECOT system (Engineered Cas12a for One-pot Test), a novel approach that combines protein engineering with one-pot detection, offering high sensitivity, specificity, and rapid response is introduced. By introducing GCN4 epitope insertions into LtCas12a and LbCas12a variants, their cis-cleavage activity, promoting efficient accumulation of amplification products is reduced. Additionally, the inclusion of scFv-Rad51 (single-chain variable fragment-Rad51) enhances Cas12a's trans-cleavage activity, amplifying signal intensity. The ECOT-Lb system demonstrated superior sensitivity in detecting low-copy HPV DNA samples, outperforming traditional qPCR in clinical tests. Achieving detection limits as low as 3 copies in under 30 min, the ECOT-Lb system is well-suited for home-based self-testing and widespread clinical diagnostics. This work provides a versatile and scalable protein engineering strategy that enhances the performance of CRISPR-based diagnostic tools, offering a promising platform for rapid molecular detection in diverse applications.

Indexed as

CRISPR-Cas SystemsEpitopesNucleic AcidsRad51 RecombinaseBacterial ProteinsCRISPR-Associated ProteinsEndodeoxyribonucleasesHumansBacterial ProteinsCas12a proteinCRISPR-Associated ProteinsEndodeoxyribonucleasesEpitopesNucleic AcidsRad51 RecombinaseCRISPR‐based diagnosticsnucleic acid detectionprotein engineering

Identifiers

PMID40888415
PMCPMC12508702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.